A Trial of Accelerated Fractionation in Localised Invasive Bladder Cancer
Completed
- Conditions
- Bladder (advanced)CancerBladder
- Registration Number
- ISRCTN82138783
- Lead Sponsor
- The Institute of Cancer Research (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Stage T2 or T3 NXMO carcinoma of the bladder defined either by clinical findings or by histopathology
2. If nodes are assessed N1 patients (single node <2 cm) are eligible, N2 and N3 patients are excluded
3. Patients with severe concurrent general medical illness especially those with inflammatory bowel disease, other malignancies (except skin cancer), recent myocardial infarction (within 3 months) or previous major pelvic surgery are excluded
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration